EU Temporarily Authorizes Sale Of Remdesivir To Treat COVID-19 Patients
Remdesivir was authorized conditional marketing by the European Medicines Agency on June 25.
Read Original Article: EU Temporarily Authorizes Sale Of Remdesivir To Treat COVID-19 Patients »